Literature DB >> 28760691

Elevated cortisol awakening response associated with early life stress and impaired executive function in healthy adult males.

Kevin Butler1, Kristel Klaus1, Laura Edwards1, Kyla Pennington2.   

Abstract

Experiencing early life stress (ELS) and subsequent dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis may play a role in the aetiology of mental health disorders. However, the exact mechanisms linking HPA-axis dysregulation with the development of psychopathology have not been fully delineated. Progress in this area is hampered by the complex and often conflicting associations found between markers of HPA-axis function and risk factors for mental health disorders such as impaired executive function (EF) and ELS. This study investigated the association of the cortisol awakening response (CAR) with ELS and EF in a healthy adult male population (n=109, aged 21-63). As previous inconsistencies in CAR and ELS association studies may be the result of not considering ELS-related factors such as cumulative exposure, type of stressor and developmental timing of ELS, these were also investigated. The main findings were that the CAR was significantly elevated in individuals reporting ELS compared to those reporting no ELS (p=0.007) and that an elevated CAR predicted poorer problem solving/planning (p=0.046). Cumulative exposure, type of stressor and developmental timing of ELS were also found to impact significantly on the CAR. These results suggest that ELS is associated with chronic changes in HPA-axis function and that these changes may be associated with impairments in problem solving/planning. Future work should investigate further the neurobiological mechanisms linking ELS, the CAR and EF and their role in conferring risk for the development of mental health disorders.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cortisol awakening response; Early life stress; Executive function; Healthy adults; Planning; Problem solving

Mesh:

Substances:

Year:  2017        PMID: 28760691     DOI: 10.1016/j.yhbeh.2017.07.013

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  6 in total

Review 1.  Promoting brain health through physical activity among adults exposed to early life adversity: Potential mechanisms and theoretical framework.

Authors:  Shannon D Donofry; Chelsea M Stillman; Jamie L Hanson; Margaret Sheridan; Shufang Sun; Eric B Loucks; Kirk I Erickson
Journal:  Neurosci Biobehav Rev       Date:  2021-10-05       Impact factor: 8.989

Review 2.  Canada's Colonial Genocide of Indigenous Peoples: A Review of the Psychosocial and Neurobiological Processes Linking Trauma and Intergenerational Outcomes.

Authors:  Kimberly Matheson; Ann Seymour; Jyllenna Landry; Katelyn Ventura; Emily Arsenault; Hymie Anisman
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

3.  Early life stress and HPA axis function independently predict adult depressive symptoms in metropolitan Cebu, Philippines.

Authors:  Andrew Wooyoung Kim; Emma K Adam; Sonny A Bechayda; Christopher W Kuzawa
Journal:  Am J Phys Anthropol       Date:  2020-08-03       Impact factor: 2.868

Review 4.  Early life adversity shapes neural circuit function during sensitive postnatal developmental periods.

Authors:  Lauren Malave; Milenna T van Dijk; Christoph Anacker
Journal:  Transl Psychiatry       Date:  2022-08-01       Impact factor: 7.989

5.  Reward sensitivity modulates the brain reward pathway in stress resilience via the inherent neuroendocrine system.

Authors:  Weiyu Hu; Xiaolin Zhao; Yadong Liu; Yipeng Ren; Zhenni Wei; Zihan Tang; Yun Tian; Yadong Sun; Juan Yang
Journal:  Neurobiol Stress       Date:  2022-09-07

6.  Developmental arsenic exposure is associated with sex differences in the epigenetic regulation of stress genes in the adult mouse frontal cortex.

Authors:  Elizabeth R Solomon; Kevin K Caldwell; Andrea M Allan
Journal:  Toxicol Appl Pharmacol       Date:  2020-02-13       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.